文献速递颈动脉与弓上血管

血清EMMPRIN水平升高提示无症状重度颈动脉狭窄患者的斑块易损性

Elevated EMMPRIN Serum Levels Indicate Plaque Vulnerability in Patients With Asymptomatic High Grade Carotid Stenosis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2022-12-15

本研究分析265例颈动脉内膜切除术患者术前血清EMMPRIN,比较症状性与无症状性狭窄及超声、病理斑块特征。结果显示回声透亮斑块及无症状易损斑块患者EMMPRIN显著升高,EMMPRIN联合临床危险因素可提高无症状患者易损斑块的预测AUC。

要点

  • 回声透亮斑块患者血清EMMPRIN高于回声增强斑块患者(p=.025)。
  • 无症状易损斑块患者EMMPRIN显著高于非易损斑块患者(p<.001)。
  • EMMPRIN联合年龄、性别、临床危险因素及双功超声可提高无症状患者易损斑块预测AUC。

核心结论

  • 超声和病理特征提示高危斑块的患者血清EMMPRIN水平升高。
  • EMMPRIN联合年龄、性别、双功超声等临床危险因素可能用于无症状患者的术前风险分层。

研究设计与样本

  • 研究纳入265例接受颈动脉内膜切除术的患者,其中症状性90例(男:女,69:21),无症状性175例(男:女,118:57)。
  • 术前血清EMMPRIN采用特异性ELISA分析,术前双功超声按回声特性分类斑块,病理分析基于美国心脏协会(AHA)分类判定易损与非易损斑块。

主要发现

  • 回声透亮斑块患者血清EMMPRIN为4480(IQR 3745,6144)pg/mL,高于回声增强斑块的4159(IQR 3418,5402)pg/mL(p=.025)。
  • 无症状易损斑块患者EMMPRIN为4875(IQR 3850,7016)pg/mL,显著高于非易损斑块的4109(IQR 3433,5402)pg/mL(p<.001)。
  • 双功超声联合年龄、性别和临床危险因素预测无症状患者易损斑块的AUC为0.71(95%CI 0.61-0.80)。
  • 加入EMMPRIN后无症状患者AUC显著提高至0.79(95%CI 0.71-0.87;p=.014)。

临床怎么用

  • 作者认为,EMMPRIN联合年龄、性别、双功超声等临床危险因素可能用于无症状患者的术前风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Carotid atherosclerosis is an important cause of cerebral ischaemic stroke. Sonographic plaque characteristics are inappropriate for exact prediction of possible future ischaemic events. Additional markers are needed to predict the clinical outcome in high grade carotid stenosis. This study aimed to test extracellular matrix metalloproteinase inducer (EMMPRIN), due to its involvement in plaque formation and destabilisation, as a potential marker of high risk vulnerable plaques. METHODS: EMMPRIN was analysed in pre-operative serum samples from patients with symptomatic and asymptomatic carotid artery stenosis by a specific ELISA. Pre-operative duplex sonography classified the atherosclerotic plaque due to echogenicity. Histopathological analysis of vulnerable and non-vulnerable plaques was based on the American Heart Association (AHA) classification. RESULTS: The study included 265 patients undergoing carotid endarterectomy: 90 (m:f, 69:21) patients with symptomatic and 175 (m:f, 118:57) with asymptomatic disease. Analysis of circulating EMMPRIN revealed significantly higher levels in patients with echolucent plaques (4 480; IQR 3 745, 6 144 pg/mL) compared with echogenic plaques (4 159; IQR 3 418, 5 402 pg/mL; p = .025). Asymptomatic patients with vulnerable plaques had significantly higher levels of EMMPRIN (4 875; IQR 3 850, 7 016 pg/mL) compared with non-vulnerable plaques (4 109; IQR 3 433, 5 402 pg/mL; p < .001). In logistic regression analysis, duplex sonography combined with age, gender, and clinical risk factors predicted vulnerable plaques in asymptomatic patients with an AUC of 0.71 (95% CI 0.61 - 0.80). EMMPRIN significantly improved the AUC in asymptomatic patients (AUC 0.79; 95% CI 0.71 - 0.87; p = .014). CONCLUSION: Patients with high risk plaques according to ultrasound and histopathological characteristics demonstrated increased serum EMMPRIN levels. EMMPRIN on top of clinical risk factors, including age, gender, and duplex sonography may be used for pre-operative risk stratification in asymptomatic patients.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kampf S, Micko A, Stojkovic S, et al. Elevated EMMPRIN Serum Levels Indicate Plaque Vulnerability in Patients With Asymptomatic High Grade Carotid Stenosis. Eur J Vasc Endovasc Surg. 2022. PMID: 36529365. doi:10.1016/j.ejvs.2022.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。